相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Autophagy receptor defects and ALS-FTLD
Veronika Majcher et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2015)
OPINION FTD and ALS-translating mouse studies into clinical trials
Lars M. Ittner et al.
NATURE REVIEWS NEUROLOGY (2015)
C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits
Jeannie Chew et al.
SCIENCE (2015)
Tau-targeting passive immunization modulates aspects of pathology in tau transgenic mice
Arne Ittner et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: Phase 1 trial outcomes
Eva L. Feldman et al.
ANNALS OF NEUROLOGY (2014)
The non-cell-autonomous component of ALS: new in vitro models and future challenges
Laura Ferraiuolo
BIOCHEMICAL SOCIETY TRANSACTIONS (2014)
Pathways Disrupted in Human ALS Motor Neurons Identified through Genetic Correction of Mutant SOD1
Evangelos Kiskinis et al.
CELL STEM CELL (2014)
Moving forward in clinical trials for ALS: motor neurons lead the way please
Baris Genc et al.
DRUG DISCOVERY TODAY (2014)
A phase II-III trial of olesoxime in subjects with amyotrophic lateral sclerosis
T. Lenglet et al.
EUROPEAN JOURNAL OF NEUROLOGY (2014)
The past, present and future of stem cell clinical trials for ALS
Gretchen M. Thomsen et al.
EXPERIMENTAL NEUROLOGY (2014)
Neuroprotective effects of the mitochondria-targeted antioxidant MitoQ in a model of inherited amyotrophic lateral sclerosis
Ernesto Miquel et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Motor Neuron Disease: A Chemical Perspective
Laura K. Wood et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
GLT-1 transporter: An effective pharmacological target for various neurological disorders
Neha Soni et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
A new inducible transgenic mouse model for C9orf72-associated GGGGCC repeat expansion supports a gain-of- function mechanism in C9orf72-associated ALS and FTD
Renate K. Hukema et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion
Jacqueline C. Mitchell et al.
ACTA NEUROPATHOLOGICA (2013)
Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons
Sandra Almeida et al.
ACTA NEUROPATHOLOGICA (2013)
Rodent models of amyotrophic lateral sclerosis
Philip McGoldrick et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Therapeutic neuroprotective agents for amyotrophic lateral sclerosis
Rachna S. Pandya et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons
Wenzhang Wang et al.
HUMAN MOLECULAR GENETICS (2013)
Premature death of TDP-43 (A315T) transgenic mice due to gastrointestinal complications prior to development of full neurological symptoms of amyotrophic lateral sclerosis
Mohammad A. Esmaeili et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2013)
Disease Animal Models of TDP-43 Proteinopathy and Their Pre-Clinical Applications
Yu-Chih Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Overexpression of ALS-Associated p.M337V Human TDP-43 in Mice Worsens Disease Features Compared to Wild-type Human TDP-43 Mice
Jonathan Janssens et al.
MOLECULAR NEUROBIOLOGY (2013)
Genetics of amyotrophic lateral sclerosis: an update
Sheng Chen et al.
MOLECULAR NEURODEGENERATION (2013)
Viral Delivery of Antioxidant Genes as a Therapeutic Strategy in Experimental Models of Amyotrophic Lateral Sclerosis
Aikaterini Nanou et al.
MOLECULAR THERAPY (2013)
The changing scene of amyotrophic lateral sclerosis
Wim Robberecht et al.
NATURE REVIEWS NEUROSCIENCE (2013)
RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention
Christopher J. Donnelly et al.
NEURON (2013)
ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43
Eveline S. Arnold et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS
Kohji Mori et al.
SCIENCE (2013)
Mechanisms, models and biomarkers in amyotrophic lateral sclerosis
Martin R. Turner et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2013)
HO-1 induction in motor cortex and intestinal dysfunction in TDP-43 A315T transgenic mice
Yansu Guo et al.
BRAIN RESEARCH (2012)
Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study
Letizia Mazzini et al.
CYTOTHERAPY (2012)
Entorhinal cortical neurons are the primary targets of FUS mislocalization and ubiquitin aggregation in FUS transgenic rats
Cao Huang et al.
HUMAN MOLECULAR GENETICS (2012)
Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis
Christophe Verbeeck et al.
MOLECULAR NEURODEGENERATION (2012)
Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis
Chi-Hong Wu et al.
NATURE (2012)
Sigma-1R Agonist Improves Motor Function and Motoneuron Survival in ALS Mice
Renzo Mancuso et al.
NEUROTHERAPEUTICS (2012)
Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability
Bilada Bilican et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Nrf2/ARE Signaling Pathway: KeyMediator in Oxidative Stress and Potential Therapeutic Target in ALS
Susanne Petri et al.
NEUROLOGY RESEARCH INTERNATIONAL (2012)
Senataxin mutations and amyotrophic lateral sclerosis
Michio Hirano et al.
AMYOTROPHIC LATERAL SCLEROSIS (2011)
Effect of genetic background on phenotype variability in transgenic mouse models of amyotrophic lateral sclerosis: A window of opportunity in the search for genetic modifiers
Terry D. Heiman-Patterson et al.
AMYOTROPHIC LATERAL SCLEROSIS (2011)
SQSTM1 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Faisal Fecto et al.
ARCHIVES OF NEUROLOGY (2011)
Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments
Vivek Swarup et al.
BRAIN (2011)
A comprehensive assessment of the SOD1G93A low-copy transgenic mouse, which models human amyotrophic lateral sclerosis
Abraham Acevedo-Arozena et al.
DISEASE MODELS & MECHANISMS (2011)
Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis
Arie Neymotin et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Glutamate receptors and signal transduction in learning and memory
Sheng Peng et al.
MOLECULAR BIOLOGY REPORTS (2011)
Amyotrophic lateral sclerosis
Matthew C. Kiernan et al.
LANCET (2011)
Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice
Ya-Fei Xu et al.
MOLECULAR NEURODEGENERATION (2011)
SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments
Peter I. Joyce et al.
MAMMALIAN GENOME (2011)
Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia
Han-Xiang Deng et al.
NATURE (2011)
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis
Merit Cudkowicz et al.
NATURE MEDICINE (2011)
Clinical genetics of amyotrophic lateral sclerosis: what do we really know?
Peter M. Andersen et al.
NATURE REVIEWS NEUROLOGY (2011)
Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis
Laura Ferraiuolo et al.
NATURE REVIEWS NEUROLOGY (2011)
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
Mariely DeJesus-Hernandez et al.
NEURON (2011)
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Alan E. Renton et al.
NEURON (2011)
Dual transplantation of human neural stem cells into cervical and lumbar cord ameliorates motor neuron disease in SOD1 transgenic rats
Leyan Xu et al.
NEUROSCIENCE LETTERS (2011)
Induced pluripotent stem cells in the study of neurological diseases
Mario A. Saporta et al.
STEM CELL RESEARCH & THERAPY (2011)
FUS Transgenic Rats Develop the Phenotypes of Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration
Cao Huang et al.
PLOS GENETICS (2011)
A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis
Robert M. Pascuzzi et al.
AMYOTROPHIC LATERAL SCLEROSIS (2010)
Mechanisms Underlying Inflammation in Neurodegeneration
Christopher K. Glass et al.
CELL (2010)
Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial
L. Mazzini et al.
EXPERIMENTAL NEUROLOGY (2010)
Decreased GLT-1 and increased SOD1 and HO-1 expression in astrocytes contribute to lumbar spinal cord vulnerability of SOD1-G93A transgenic mice
Yansu Guo et al.
FEBS LETTERS (2010)
Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target
Sian C. Barber et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U
Kuen-Jer Tsai et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Wild-Type Human TDP-43 Expression Causes TDP-43 Phosphorylation, Mitochondrial Aggregation, Motor Deficits, and Early Mortality in Transgenic Mice
Ya-Fei Xu et al.
JOURNAL OF NEUROSCIENCE (2010)
TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia
Ian R. A. Mackenzie et al.
LANCET NEUROLOGY (2010)
Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS
Jane O. Johnson et al.
NEURON (2010)
TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration
Hans Wils et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Creatine for amyotrophic lateral sclerosis/motor neuron disease
Daniel M. Pastula et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2010)
Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS)
Rongzhen Zhang et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration
Iga Wegorzewska et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis
T. J. Kwiatkowski et al.
SCIENCE (2009)
A systematic review of antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease
Richard W. Orrell et al.
AMYOTROPHIC LATERAL SCLEROSIS (2008)
Design, power, and interpretation of studies in the standard murine model of ALS
Sean Scott et al.
AMYOTROPHIC LATERAL SCLEROSIS (2008)
Nuclear Erythroid 2-Related Factor 2-Antioxidative Response Element Signaling Pathway in Motor Cortex and Spinal Cord in Amyotrophic Lateral Sclerosis
Alexander Sarlette et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Messenger RNA Oxidation Occurs Early in Disease Pathogenesis and Promotes Motor Neuron Degeneration in ALS
Yueming Chang et al.
PLOS ONE (2008)
CD4+T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS
David R. Beers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS
Isaac M. Chiu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons
John T. Dimos et al.
SCIENCE (2008)
TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis
Jemeen Sreedharan et al.
SCIENCE (2008)
Angiogenin loss-of-function mutations in amyotrophic lateral sclerosis
David Wu et al.
ANNALS OF NEUROLOGY (2007)
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial
Paul H. Gordon et al.
LANCET NEUROLOGY (2007)
Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis
Thierry Bordet et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease
R. W. Orrell et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2007)
Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice
C-P Zhao et al.
CYTOTHERAPY (2007)
Lost in translation: Treatment trials in the SOD1 mouse and in human ALS
Michael Benatar
NEUROBIOLOGY OF DISEASE (2007)
TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Tetsuaki Arai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Oxidative stress in ALS: A mechanism of neurodegeneration and a therapeutic target
Sian C. Barber et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2006)
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Manuela Neumann et al.
SCIENCE (2006)
MCP-1 chemokine receptor CCR2 is decreased on circulating monocytes in sporadic amyotrophic lateral sclerosis (sALS)
Rongzhen Zhang et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Familial ALS-superoxide dismutases associate with mitochondria and shift their redox potentials
Alberto Ferri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Trial of celecoxib in amyotrophic lateral sclerosis
Merit E. Cudkowicz et al.
ANNALS OF NEUROLOGY (2006)
New ideas for therapy in ALS: Critical considerations
Ettore Beghi et al.
AMYOTROPHIC LATERAL SCLEROSIS (2006)
Manganese porphyrin given at symptom onset markedly extends survival of ALS mice
JP Crow et al.
ANNALS OF NEUROLOGY (2005)
Excitotoxicity and Amyotrophic Lateral Sclerosis
P. van Damme et al.
NEURODEGENERATIVE DISEASES (2005)
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
JD Rothstein et al.
NATURE (2005)
Cytochrome c association with the inner mitochondrial membrane is impaired in the CNS of G93A-SOD1 mice
IG Kirkinezos et al.
JOURNAL OF NEUROSCIENCE (2005)
A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis
AL Nishimura et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
The AMPA receptor antagonist NBQX prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis
P Van Damme et al.
NEUROSCIENCE LETTERS (2003)
Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS
DB Drachman et al.
ANNALS OF NEUROLOGY (2002)
Minocycline slows disease progression in a mouse model of arnyotrophic lateral sclerosis
J Kriz et al.
NEUROBIOLOGY OF DISEASE (2002)
Minocycline delays disease onset and mortality in a transgenic model of ALS
L Van Den Bosch et al.
NEUROREPORT (2002)
Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice
S Zhu et al.
NATURE (2002)
Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients
FR Wiedemann et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients
N Shibata et al.
BRAIN RESEARCH (2001)
N-acetyl-L-cysteine improves survival and preserves motor performance in an animal model of familial amyotrophic lateral sclerosis
OA Andreassen et al.
NEUROREPORT (2000)
Mitochondrial DNA deletion mutation levels are elevated in ALS brains
GK Dhaliwal et al.
NEUROREPORT (2000)
分享论文
